Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Burdock Root

Tighter Controls On Cold And Flu Remedies Help Fight Against Class A Drugs
Cold and flu remedies containing pseudoephedrine and ephedrine will remain as pharmacy (P) medicines after tighter controls were found to minimise the misuse of these ingredients in the illegal manufacture of methylamphetamine (crystal meth).
generic viagra online
AbbeyMoor Medical Receives FDA Approval For Design Improvements To The Spanner(TM) Prostatic Stent
AbbeyMoor Medical Inc., a developer and manufacturer of medical devices for the management and treatment of prostatic obstruction, announced that it has received PMA approval from the US Food and Drug Administration (FDA) for design changes to their flagship product, The Spanner(TM) Prostatic Stent.
News of the day
Opinion Pieces, Editorials Comment On Obama's Notre Dame Commencement Speech
Several newspapers recently published opinion pieces and editorials regarding President Obama"s commencement address at the University of Notre Dame on Sunday. Summaries appear below.~ Austin Hill, U.S. News and World Report: A "careful look" at the controversy surrounding Notre Dame"s invitation to Obama "suggests that ... the Catholic Church in America is neither communicating very clearly to the broader American society, nor is it communicating very clearly among its own members," columnist Hill writes. Hill asks, "[I]f Catholics need to criticize a political figure even when he is "right" on the abortion issue, can they, or should they, praise a political figure even when he is "wrong" on the abortion issue" but "right" on other moral issues? He adds, "The bishops need to answer this question, in no uncertain terms, and they need to do so with clarity" (Hill, U.S. News and World Report, 5/20).~ William Saletan, Slate: Abortion is "the classic multidimensional issue," and "Obama"s acknowledgment of the issue"s complexity is important for two reasons," author and Slate correspondent Saletan writes. The first reason is that Obama is "dropping the pretense of a conclusive answer," and the second is that "even strategic symbolic dialogue can bring unforeseen consequences," Saletan writes (Saletan, Slate, 5/20).~ Julia Duin, Washington Times: A number of things "did not seem right" about Obama"s speech,"[e]specially about "common ground" on an issue that has none" -- abortion rights, columnist Duin writes. Duin asks, "Does this "common ground" idea really work? On peripheral issues, yes. On life-and-death issues, no." According to Duin, "It seems that one side of the debate is always told it needs to move to the center on a given issue, while the other side is told it needs to stand firm." She adds that Obama"s speech highlighted "a huge disconnect," possibly "that some issues don"t have a common ground" (Duin, Washington Times, 5/21).~ Marybeth Hicks, Washington Times: In his speech, Obama "shared a world view that people of all strongly held beliefs must consider: While we will never agree on certain matters of principle, we should still find ways to lift up mankind through cooperation and service and love," columnist Hicks writes. Hicks says that she would like "Obama to send a copy of that speech to Harry Knox" -- director of the religion and faith program at the Human Rights Campaign and a member of Obama"s White House Council on Faith-based and Neighborhood Partnerships -- because Knox "must learn to respect the right of Catholics and of our church to hold principled beliefs of our own" (Hicks, Washington Times, 5/20).~ Dallas Morning News: Obama "[o]nce again ... displayed his gift for making his most strident opponents marginalize themselves" by "com[ing] across as the kind of politician who genuinely sees those who disagree with him as opponents, not enemies," a Morning News editorial says. "When a strong abortion-rights supporter like Obama is not only honored at the nation"s most important Catholic university (in terms of cultural symbolism), but enthusiastically embraced, times are changing," it adds (Dallas Morning News, 5/18).~ Kansas City Star: Most Americans "have more in common with the 12,000 graduates, families and friends who were inside the Notre Dame arena than with the demonstrators outside" and "are willing to listen to different views and ... seek a middle ground that would lessen the [abortion] issue"s grip on political discourse," a Star editorial states. It continues, "Instead of ostracizing those of different views, Americans would do better to follow the path suggested by Obama: Reduce unintended pregnancies, make adoption more available and provide "care and support for women who do carry their children to term"" (Kansas City Star, 5/18).~ Baltimore Sun: Obama "met the challenge head-on" of speaking at Notre Dame amid the protests through "his faith in the ability of reasonable people to disagree and still find common gro
Medical Devices

International Study Of Polar Body Screening Launced By ESHRE

The efficacy of preimplantation genetic screening (PGS) has been one of the most hotly disputed subjects in assisted reproduction over the past few years. None of the trials carried out so far has shown conclusively whether it works or not. Now the European Society of Human Reproduction and Embryology (ESHRE) Task Force on PGS has decided to try to find out if a novel method of doing PGS using polar body biopsy and chromosome array analysis offers a possible solution. Professor Joep Geraedts, ESHRE chairman, told the 25th annual conference of the society on June 28 that the Task Force would carry out a pilot study of PGS in one of each pair of 23 chromosomes in polar bodies, tiny cells that are a by-product of egg development, in collaboration with BlueGnome, a DNA technology company based in Cambridge, UK. Once a pilot study has shown that the technique is feasible, the researchers intend to carry out an international randomised trial. The first phase will begin in September 2009 in two centres: the University of Bonn, Germany (Dr. Markus Montag and Professor Hans van der Ven), and SISMER, Bologna, Italy (Dr. Luca Gianaroli and Dr. Cristina Magli). "Because this is a new technology," said Dr. Gianaroli, "we need to carry out a pilot study in order to be sure that the analysis can be completed within a time period that allows for fresh transfer, as well as to ensure the reliable identification of the chromosomal status of an oocyte in at least 90% of polar body biopsy attempts." The two centres chosen for the pilot study have considerable experience in the field of polar body biopsy because legislation in their countries restricts the possibility of undertaking embryo biopsy at a later stage of development. The data from the study will be independently analysed by Dr. Sjoerd Repping, from the Academic Medical Centre in Amsterdam, who carried out a randomised trial of PGS on three-day old embryos published in 2007. The researchers hope to present the data at ESHRE 2010 in Rome and to start the RCT with the involvement of at least six centres in different European countries later the same year. Oocytes to be used in the pilot phase will be obtained from volunteer patients who have given consent for their use in this study. There will be no age restrictions on those donating their eggs. By biopsying polar bodies at an early stage of egg development, the researchers believe that not only are they using a less invasive method of chromosome analysis, but also a more accurate one. "A biopsied blastomere, or very early embryo, is not a true representation of the other cells in that same embryo," said Professor Geraedts. "This mosaicism confuses the analyses and we don"t know what it means for that embryo in the later stages of its development." 24sure, the novel molecular technique to be used in both phases of the trial was developed by BlueGnome and is based on DNA amplification and microarray technology, which enables scientists to look at all the chromosomes at the same time. This is, in theory, far more powerful than the method of fluorescent in situ hybridisation or FISH, which has been used thus far. "It is because we think this subject is so important," said Professor Geraedts, "that we have decided to launch our first-ever clinical study. We hope that we will be able to answer the outstanding questions about PGS once and for all. If we can show that polar body screening works, it will be a major step forward in improving IVF treatment for many women who have persistent difficulty in getting pregnant and maintaining a pregnancy." Mary Rice European Society for Human Reproduction and Embryology


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009